Guyer William, Chief Officer of Corcept Therapeutics CORT, has filed 0 purchases and 37 sales on the open market. Over the past 12 months that comes to a net sale of $11.1M. The latest trade was on 06/02.

Guyer William

Chief Development Officer

Company

Corcept Therapeutics CORT

First filing

23/02/15

Trades

121 trades

Buys / sales

0 / 37

12-month net buying

−$11.1M

Last trade

06/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan	06/02	06/04	20,000 sh	$70.60	$1,412,000	−83.4%
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan	05/05	05/07	20,000 sh	$51.83	$1,036,600	−90.0%
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan	04/07	04/08	20,000 sh	$40.97	$819,400	−90.0%
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan	03/20	03/24	11,767 sh	$36.01	$423,729.67	−84.1%
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan	03/04	03/06	8,233 sh	$35.99	$296,305.67	−78.7%
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan	02/03	02/05	20,000 sh	$40.87	$817,400	−94.2%
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan	01/06	01/08	20,000 sh	$35.18	$703,600	−94.2%
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan · Amendment	25/11/25–25/12/02	25/12/03	24,500 sh3 trades	$80.23avg.	$1,965,581.2	No record
Corcept TherapeuticsCORT	Open-market sale	25/11/25	25/11/26	4,500 sh	$80.90	$364,050	−85.1%
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan	25/11/05	25/11/07	20,000 sh3 trades	$75.36avg.	$1,507,174.96	−79.1%
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan	25/10/07	25/10/09	20,000 sh	$89.94	$1,798,800	−79.1%
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan	25/09/02	25/09/04	20,000 sh2 trades	$70.49avg.	$1,409,826.76	−78.5%
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan	25/08/08	25/08/12	35,007 sh	$71.77	$2,512,452.39	−86.4%
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan	25/08/05	25/08/07	14 sh	$71.77	$1,004.78	−0.3%
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan	25/07/17–25/07/18	25/07/21	4,879 sh2 trades	$73.48avg.	$358,488.92	−47.1%
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan	25/07/01	25/07/03	100 sh	$73.51	$7,351	−1.8%
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan	25/06/10	25/06/12	20,000 sh2 trades	$72.42avg.	$1,448,401.98	−78.5%
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan	25/05/16	25/05/20	32,262 sh	$74.17	$2,392,872.54	−85.5%
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan	25/05/06	25/05/08	7,060 sh	$74.31	$524,628.6	−56.3%
Corcept TherapeuticsCORT	Open-market sale10b5-1 plan	25/04/01	25/04/02	678 sh	$114.51	$77,637.78	−11.0%